AfDB Moves To Cut $14bn Annual Import of Medicine Into Africa

Cat:

Related stories

Tinubu Departs Saint Lucia, Heads to Brazil for BRICS Summit

By Abiola Olawale President Bola Ahmed Tinubu departed Saint Lucia...

2027: Drama, Intrigues as Julius Abure Tells Otti to Quit Labour Party

By Abiola Olawale In a dramatic turn of events, Barrister...

FG Secures $100m for Lagos-Calabar Project from ECOWAS Bank

By Abiola Olawale The Nigerian government has reportedly secured a...

Ex- Arsenal Star Thomas Partey Faces Rape, Sexual Assault Charges in UK

By Abiola Olawale The Metropolitan Police have formally charged former...

Edwin Cortes: Prefers Being A Small Puerto Rican Than Big American

By Owei Lakemfa To be a citizen of the United...

The Board of Directors of the African Development Bank (AfDB), has approved the establishment of African Pharmaceutical Technology Foundation for A,frica’s access to technologies.

According to the bank, this is for the manufacture of medicines, vaccines and other pharmaceutical products.

In a statement by the bank”s Communication and External Relations Department on Monday in Abuja, the AfDB President, Dr Akinwumi Adesina described the development as a leap for Africa.

He said, with Africa importing more than 70 per cent of all the medicines it needs and consuming 14 billion dollars per year, the establishment of the Foundation was a major development.

Adesina said “Global efforts to rapidly expand manufacturing of essential pharmaceutical products including vaccines in developing countries, particularly in Africa, to assure greater access, had been hampered.

“This has been hampered by intellectual property rights protection and patents on technological know-how, manufacturing processes and trade secrets.

“African pharmaceutical companies do not have the scouting and negotiation capacity, and bandwidth to engage with global pharmaceutical companies.
“They have been marginalised and left behind in complex global pharmaceutical innovations.”

He decried that of 35 companies which recently signed a licence with America’s Merck to produce Nirmatrelvir, a COVID-19 drug, none was African.

According to him, no institution exists in Africa to support the practical implementation of Trade Related Intellectual Property Rights (TRIPs) on nonexclusive or exclusive licencing of proprietary technologies, know-how and processes.

He expressed optimism that the Foundation would fill existing gaps when fully established.

“It will be staffed with world-class experts on pharmaceutical innovation and development, intellectual property rights, and health policy.

“It will act as a transparent intermediator advancing and brokering the interests of the African pharmaceutical sector with global and other Southern pharmaceutical companies,” the statement said.

It quoted Adesina as saying, “Africa must have a health defence system, which must include three major areas.

“Revamping Africa’s pharmaceutical industry, building Africa’s vaccine manufacturing capacity, and building Africa’s quality healthcare infrastructure.”
The statement said that African leaders had called on AfDB to facilitate establishment of the African Pharmaceutical Technology Foundation.

It said that the AfDB president, who presented the case for the institution to the African Union at the Summit in Addis Ababa in February, said it was a bold initiative.

“Africa can no longer outsource the healthcare security of its 1.3 billion citizens to the benevolence of others.

”With this bold initiative, the African Development Bank has made good on that commitment.

“The decision is a major boost to the health prospects of a continent.

“A continent that has been battered for decades by the burden of several diseases and pandemics such as COVID-19, but with very limited capacity to produce its own medicines and vaccines.”

The statement noted that the World Trade Organisation WTO and the World Health Organisation (WHO), welcomed the bank’s decision to establish the Foundation.

It quoted the Director-General of the WTO Dr. Ngozi Okonjo-Iweala as saying, “the African Pharmaceutical Technology Foundation is innovative thinking and action by the African Development Bank.

“It provides part of the infrastructure needed to assure an emergent pharmaceutical industry in Africa.”
The statement also quoted the Director-General of WHO, Dr. Tedros Ghebreyesus as saying

“establishing the Foundation was a game changer”.
It also quoted him as saying it was a game changer “on accelerating access of African pharmaceutical companies to IP-protected technologies and know-how in Africa,”
On activities of the Foundation, the statement said that it would prioritise technologies, products and processes focused primarily on diseases that were widely prevalent in Africa.
It noted that the Foundation would build human and professional skills, research and development ecosystem, while supporting upgrade of manufacturing plant capacities and regulatory quality to meet WHO standards.

According to the statement, the African Pharmaceutical Technology Foundation is being established under the auspices of the AfDB,

It stated that the Foundation would operate independently and raise funds from various stakeholders including governments, development finance institutions, philanthropic organisations among others.

“The Foundation will boost the African Development Bank’s commitment to spend at least three billion dollars over the next 10 years.

“This is to support the pharmaceutical and vaccine manufacturing sector under its Vision 2030 Pharmaceutical Action Plan.

“The Foundation’s areas of work will also be an asset to all other current investments into pharmaceutical production in Africa.

“Rwanda will host the African Pharmaceutical Technology Foundation.

“It will have its own governance and operational structures, while promoting and brokering alliances between foreign and African pharmaceutical companies.”

The statement further pointed out that the Foundation would strengthen local pharmaceutical companies to engage in local production initiatives with systematic technology among others.

The Foundation according to the statement, will work with African Union Commission, European Union Commission, WHO and other stakeholders, for collaboration in developed countries and developing countries. (NAN)

Agency Report
Agency Report
Hamilton Nwosa is an experienced, and committed communication, business, administrative, data and research specialist . His deep knowledge of the intersection between communication, business, data, and journalism are quite profound. His passion for professional excellence remains the guiding principle of his work, and in the course of his career spanning sectors such as administration, tourism, business management, communication and journalism, Hamilton has won key awards. He is a delightful writer, researcher and data analyst. He loves team-work, problem-solving, organizational management, communication strategy, and enjoys travelling. He can be reached at: hamilton_68@yahoo.com

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

NDN
Latest News
Tinubu Departs Saint Lucia, Heads to Brazil for BRICS Summit2027: Drama, Intrigues as Julius Abure Tells Otti to Quit Labour PartyFG Secures $100m for Lagos-Calabar Project from ECOWAS BankEx- Arsenal Star Thomas Partey Faces Rape, Sexual Assault Charges in UKEdwin Cortes: Prefers Being A Small Puerto Rican Than Big AmericanJune 12 And The International Pursuit of Justice For Abiola, By Femi FalanaBreaking Down the West’s $146 Billion 2024 Defence Technology InvestmentG7 vs. the World: GDP, Population, and Military StrengthUS drillers cut oil and gas rigs for 10th week in a row, Baker Hughes saysExclusive! Tinubu Tips Late Ajimobi's Wife, Florence, Others for Ambassadorial PostsTinubu Mourns, Pays Tribute to Legendary Super Eagles Goalkeeper Peter RufaiNatasha vs Akpabio: Court Orders Senate President To Recall Senator NatashaHadi Sirika Denies Defection to ADC Coalition Rumors, Reaffirms Loyalty to Buhari, APCChina Snubs U.S. Crude for Third Month, Even as Ethane Trade RestartsHow Super Eagles Icon Peter Rufai passed Away at 61
X whatsapp